Neurology
Found 123 results
Filters: Keyword is Middle Aged  [Clear All Filters]
2017
Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.  2017.  No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K et al..  2017.  Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.. N Engl J Med. 376(3):221-234.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..  2017.  Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..  2017.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.
Nguyen TD, Spincemaille P, Gauthier SA, Wang Y.  2017.  Rapid whole brain myelin water content mapping without an external water standard at 1.5T.. Magn Reson Imaging. 39:82-88.
Merkler AE, Ch'ang J, Parker WE, Murthy SB, Kamel H.  2017.  The Rate of Complications after Ventriculoperitoneal Shunt Surgery.. World Neurosurg. 98:654-658.
Parikh NS, Burch JE, Kamel H, DeAngelis LM, Navi BB.  2017.  Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors.. J Stroke Cerebrovasc Dis. 26(10):2396-2403.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.
2016
Parikh NS, Navi BB, Kumar S, Kamel H.  2016.  Association between Liver Disease and Intracranial Hemorrhage.. J Stroke Cerebrovasc Dis. 25(3):543-8.
Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R et al..  2016.  Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.. Contemp Clin Trials. 50:166-77.
Ebben MR, Krieger AC.  2016.  Diagnostic accuracy of a mathematical model to predict apnea-hypopnea index using nighttime pulse oximetry.. J Biomed Opt. 21(3):35006.
Chiang GC, Pinto S, Comunale JP, Gauthier SA.  2016.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.. J Neuroimaging. 26(3):289-95.
Merkler AE, Parikh NS, Chaudhry S, Chait A, Allen NC, Navi BB, Kamel H.  2016.  Hospital revisit rate after a diagnosis of conversion disorder.. J Neurol Neurosurg Psychiatry. 87(4):363-6.
Bourre B, Gueudry J, Lefaucheur R, Borden A, Maltête D, Patel SS, Van Tassel SHaseltine, Gupta MP, Orlin A, Nealon NM.  2016.  Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.. Neurology. 86(3):312-3.
Zhang Y, Gauthier SA, Gupta A, Chen W, Comunale J, Chiang GC-Y, Zhou D, Askin G, Zhu W, Pitt D et al..  2016.  Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.. AJNR Am J Neuroradiol. 37(9):1629-35.
Murthy SB, Urday S, Beslow LA, Dawson J, Lees K, W Kimberly T, Iadecola C, Kamel H, Hanley DF, Sheth KN et al..  2016.  Rate of perihaematomal oedema expansion is associated with poor clinical outcomes in intracerebral haemorrhage.. J Neurol Neurosurg Psychiatry. 87(11):1169-1173.
Navi BB, Parikh NS, Lerario MP, Merkler AE, Lappin RI, Fahimi J, Iadecola C, Kamel H.  2016.  Risk of Intracerebral Hemorrhage after Emergency Department Discharges for Hypertension.. J Stroke Cerebrovasc Dis. 25(7):1683-1687.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.  2016.  Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
2015
Kuceyeski AF, Vargas W, Dayan M, Monohan E, Blackwell C, Raj A, Fujimoto K, Gauthier SA.  2015.  Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.. AJNR Am J Neuroradiol. 36(4):702-9.
Eskreis-Winkler S, Deh K, Gupta A, Liu T, Wisnieff C, Jin M, Gauthier SA, Wang Y, Spincemaille P.  2015.  Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging.. J Magn Reson Imaging. 42(1):224-9.
Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, Williams S, Pirraglia E, Vallabhajosula S, McHugh P et al..  2015.  Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.. J Nutr Health Aging. 19(4):413-23.
Deh K, Nguyen TD, Eskreis-Winkler S, Prince MR, Spincemaille P, Gauthier S, Kovanlikaya I, Zhang Y, Wang Y.  2015.  Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.. J Magn Reson Imaging. 42(6):1592-600.
Merkler AE, Chu SY, Lerario MP, Navi BB, Kamel H.  2015.  Temporal relationship between infective endocarditis and stroke.. Neurology. 85(6):512-6.